SENJU PHARMACEUTICAL CO.,LTD. (E00965) Stock Price

Senju Pharmaceutical is a pharmaceutical manufacturer specializing in ophthalmology and otolaryngology. The company's core business is the manufacturing and sales of ophthalmic and otolaryngological pharmaceuticals, and it also handles contact lens solutions and veterinary pharmaceuticals. By leveraging the specialized expertise it has developed since its founding and concentrating on these specific areas, the company has built competitive advantages.

The company's primary customers are medical institutions, pharmacies, and animal hospitals, providing a stable revenue base through prescription drugs. Pharmaceutical operations form the core of revenues, and the company achieves continuous growth through product development and sales in the highly specialized fields of ophthalmology and otolaryngology.

The company's business is divided into two segments: pharmaceutical operations and other operations. The pharmaceutical segment manufactures and sells ophthalmic and otolaryngological pharmaceuticals, contact lens solutions, and veterinary pharmaceuticals. The other operations segment handles cosmetic raw materials, medical devices, and supplements. The group as a whole comprises 9 subsidiaries and 2 affiliated companies, though some are excluded from consolidation due to business scale considerations.

Senju Pharmaceutical is executing a comprehensive growth strategy centered on three priority initiatives under its medium-term management plan from 2021 to 2025. To address diverse patient needs, the company is exploring new business opportunities and expanding value delivery by combining pharmaceutical products with adjacent businesses. This approach aims to provide patients, consumers, and society with a broader range of service options.

The company's key investment areas focus on developing global strategic products in four target therapeutic areas: retinal diseases, corneal diseases, glaucoma, and frontier fields. As a differentiation strategy, the company is strengthening its market presence through continuous new product launches aligned with medical needs and enhanced customer communication tailored to their requirements. In research and development, the company is acquiring new pipelines to establish market leadership and advancing innovation in existing businesses to enhance value delivery.

For business expansion, the company is undertaking structural reforms including optimizing cost structures through value chain review and improving operational efficiency through digital technology and data utilization. Senju Pharmaceutical is also prioritizing the establishment and maintenance of compliance systems, particularly in regulatory affairs, to prevent legal violations. By pursuing fundamental business improvements through structural reform, the company aims to establish an efficient value delivery system. Through these initiatives, the company is steadily executing a strategy to achieve sustainable growth despite the challenging pharmaceutical industry environment.